CN108813598A - A kind of food materials composition eradicating hypertension and cardiovascular and cerebrovascular disease - Google Patents
A kind of food materials composition eradicating hypertension and cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN108813598A CN108813598A CN201810732438.7A CN201810732438A CN108813598A CN 108813598 A CN108813598 A CN 108813598A CN 201810732438 A CN201810732438 A CN 201810732438A CN 108813598 A CN108813598 A CN 108813598A
- Authority
- CN
- China
- Prior art keywords
- food materials
- materials composition
- cardiovascular
- cerebrovascular disease
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 52
- 239000000463 material Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 38
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 37
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 34
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 34
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 27
- 235000021419 vinegar Nutrition 0.000 claims abstract description 27
- 239000000052 vinegar Substances 0.000 claims abstract description 27
- 241000234314 Zingiber Species 0.000 claims abstract description 26
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 26
- 235000008397 ginger Nutrition 0.000 claims abstract description 26
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 11
- 238000009835 boiling Methods 0.000 claims abstract description 4
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 244000248349 Citrus limon Species 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 2
- 229960000830 captopril Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000010649 ginger oil Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- -1 phellandium Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000019617 piquancy Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of radical cure hypertension and the food materials composition of cardiovascular and cerebrovascular disease, the food materials composition to be made of apple vinegar, lemon, ginger.The invention also discloses a kind of radical cure hypertension and the preparation methods of the food materials composition of cardiovascular and cerebrovascular disease, include the following steps：1) after cleaning lemon, ginger, slice is added in apple vinegar, and high fire is boiled, and small fire closes fire after enduring half an hour slowly after boiling；2) it filters, is saved in the cooling postposition refrigerator of resulting filtrate.The present invention carries out compatibility with apple vinegar, lemon, ginger special ratios, synergistic function enhancing, it is verified through clinical test, food materials composition of the invention has radical cure effect well to hypertension and cardiovascular and cerebrovascular disease, has the advantages that significant in efficacy, safe without toxic side effect, can take for a long time.Preparation process of the invention is simple, and strong operability, production cost is low, is suitable for being mass produced.
Description
Technical field
The present invention relates to technical field of health care food, and in particular to a kind of food materials for eradicating hypertension and cardiovascular and cerebrovascular disease
Composition.
Background technique
Cardiovascular and cerebrovascular disease is the general designation of cardiovascular disease and cranial vascular disease, refer to due to hyperlipidemia, blood is sticky,
The common name of ischemic or hemorrhagic disease occurs for heart caused by atherosclerosis, hypertension etc., brain and body tissue.
With the quickening of continuous improvement of people's living standards and work rhythm, the illness rate of cardiovascular and cerebrovascular disease increases year by year
Add, and some cardiovascular and cerebrovascular diseases, if hypertension is because of incidence of occult, thus it is ignored, often just found in health examination.Separately
Outside since the big diet of people's psychology stress is unbalanced, environmental pollution does not get enough athletic exercise, and a large amount of lipid material can not generation
It thanks, has then resulted in the accumulation of internal lipid material, so that hyperlipidemia, hypertension, hyperglycemia, obesity etc. are further obvious, this
And the main reason for causing cardiovascular and cerebrovascular disease incidence persistently to rise.
Once this kind of disease must be gone up, less serious case needs maintenance of taking medicine for a long time, and severe one needs to spend a large amount of money that hospital is gone to rescue
It controls, very big financial burden and psychological pressure is caused to family.In order to prevent and treat above-mentioned disease, there are many related in recent years
Drug is increasingly developed, and so-called there's no such thing as a totally safe medicine, and many drugs, not only expensive price, but also effect is unknown after taking
It is aobvious.
Summary of the invention
Of the existing technology in order to solve the problems, such as, the purpose of the present invention is to provide a kind of radical cure hypertension and heart and brain blood
The food materials composition of pipe disease, the food materials composition have significant in efficacy, safe without toxic side effect, at low cost, production method is simple
The advantages that single easy to operate.
To achieve the above object, the first aspect of the present invention provides a kind of food for eradicating hypertension and cardiovascular and cerebrovascular disease
Material composition, the food materials composition are made of apple vinegar, lemon, ginger.
Further, according to parts by weight, the food materials composition is by 500 parts of apple vinegar, 100-200 parts of lemon, ginger
20-60 parts are made.
Further, according to parts by weight, the food materials composition is by 500 parts of apple vinegar, 120-160 parts of lemon, ginger
30-50 parts are made.
Further, according to parts by weight, the food materials composition is by 500 parts of apple vinegar, 140 parts of lemon, 40 parts of ginger
It is made.
The second aspect of the present invention provides a kind of preparation of food materials composition for eradicating hypertension and cardiovascular and cerebrovascular disease
Method the described method comprises the following steps：
1) after cleaning lemon, ginger, slice is added in apple vinegar, high fire is boiled, and small fire endures half an hour slowly after boiling
Fire is closed afterwards；
2) it filters, is saved in the cooling postposition refrigerator of resulting filtrate.
Further, 500 parts by weight of apple vinegar, lemon 100-200 parts by weight, ginger 20-60 parts by weight.
The third aspect of the present invention provides above-mentioned food materials composition in preparation radical cure hypertension and cardiovascular and cerebrovascular disease
Health care product in application.
The fourth aspect of the present invention provides above-mentioned food materials composition in preparation radical cure hypertension and cardiovascular and cerebrovascular disease
Drug in application.
The effect for each raw material that the present invention uses is as follows：
Apple vinegar：It is the product of apple deep processing, it is using apple as raw material, through alcoholic fermentation, acetic fermentation brew
At one kind is full of nutrition, flavorful acid health care condiment.Tart flavour in apple vinegar is rich in organic in vinegar liquid
Acid also contains malic acid, succinic acid, lactic acid, citric acid, hydroxyacetic acid in addition to acetic acid.Studies have shown that apple vinegar is in addition to its crowd
Well known antibacterial activity effect is outer, can also reduce blood pressure, anti-oxidant, and mitigating diabetes influences, and prevents cardiovascular disease, promotees
Into metabolism etc..
Lemon：Rich in vitamin C, carbohydrate, calcium, phosphorus, iron, vitamin B1, vitamin B2, niacin, quininic acid, citric acid,
Malic acid, aurantiamarin, aurantiin, coumarin, a large amount potassium element and low amounts sodium element etc., it is highly beneficial to human body.Vitamin C energy
The generation of human body various tissues and cytoplasm is maintained, and keeps their normal physiological functions.The intracorporal matrix of people, bonding and
Collagen etc. requires vitamin C to protect.When vitamin C lacks, the interstitial jelly between cell also just and then becomes
It is few.In this way, cell tissue will become fragile, the ability for resisting external force is lost, human body is easy for scurvy occur, it is used there are also more
On the way, such as the effects of preventing cold, stimulation hematopoiesis and anticancer.It is early on the books in ancient medical book.Written by pharmacy man of Ming Dynasty Li Shizhen (1518-1593 A.D.)《Book on Chinese herbal medicine
Detailed outline》Middle record lemon has the function of to promote the production of body fluid, quench the thirst, driving away summer heat etc..Lemon juice is bitter in taste, warm, nontoxic.《Luchuan book on Chinese herbal medicine》It says
Citron fruit, skin juice etc., which have, to be dredged stagnant, stomach invigorating, relieves pain, controls the efficiency such as stasis abdominal pain do not feel like eating.Modern medicine thinks that lemon is
The medicine food for preventing cardiovascular disease.Due to citric acid in human body and calcium binding is at a kind of soluble complexes, to alleviate
Calcium ion plays the role of promoting blood clotting.Therefore, hypertension, Patients With Myocardial Infarction often drink lemonade, have very to symptom is improved
Big benefit.
Ginger：Belong to Zingiber zingiber herbaceos perennial and annual vegetable crop.Ginger is full of nutrition, and has
Unique flavor can be used as a kind of important flavouring.Nature and flavor are pungent, tepor.Contain pungent and fragrance ingredient.Piquancy component is one
" zingerone " in kind armaticity stearopten.Wherein it is mainly ginger oil terpene, phellandium, camphor terpene, gingerol, folium eucalypti olein, forms sediment
Powder, mucus.The secretion that can be promoted blood circulation with digestive juice has cold dispelling and orectic effect, while having town to spit, town
Bitterly, anti-inflammation detumescence, expelling parasite and antiviral effect.Can assist in the treatment of influenza, pneumonia, bronchiectasis, pertussis,
Acute tonsillitis, the illnesss such as thick phlegm, trichomonas vaginitis, irregular menstruation, skin tinea of coughing.Terpenoid in ginger,
Such as ginger oil alcohol, zingerone, borneol citral, they all have stronger bactericidal effect.
The invention has the advantages that：
1, the present invention carries out compatibility with apple vinegar, lemon, ginger special ratios, and synergistic function enhancing is tried through clinic
Verifying, food materials composition of the invention to hypertension and cardiovascular and cerebrovascular disease have well radical cure effect, have it is significant in efficacy,
Safe without toxic side effect, the advantages of can taking for a long time.
2, preparation process of the invention is simple, and strong operability, production cost is low, is suitable for being mass produced.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..
Embodiment 1
A kind of radical cure hypertension of the present embodiment and the food materials composition of cardiovascular and cerebrovascular disease, by 500 grams of apple vinegar, lemon
100 grams, ginger 20 restrain at.
The preparation method of the food materials composition is：
1) after cleaning lemon, ginger, slice is added in apple vinegar, high fire is boiled, and small fire endures half an hour slowly after boiling
Fire is closed afterwards；
2) it filters, is saved in the cooling postposition refrigerator of resulting filtrate.
Embodiment 2
A kind of radical cure hypertension of the present embodiment and the food materials composition of cardiovascular and cerebrovascular disease, by 500 grams of apple vinegar, lemon
150 grams, ginger 60 restrain at.
The preparation method is the same as that of Example 1 for the food materials composition.
Embodiment 3
A kind of radical cure hypertension of the present embodiment and the food materials composition of cardiovascular and cerebrovascular disease, by 500 grams of apple vinegar, lemon
180 grams, ginger 30 restrain at.
The preparation method is the same as that of Example 1 for the food materials composition.
Embodiment 4
A kind of radical cure hypertension of the present embodiment and the food materials composition of cardiovascular and cerebrovascular disease, by 500 grams of apple vinegar, lemon
140 grams, ginger 40 restrain at.
The preparation method is the same as that of Example 1 for the food materials composition.
Embodiment 5
A kind of radical cure hypertension of the present embodiment and the food materials composition of cardiovascular and cerebrovascular disease, by 500 grams of apple vinegar, lemon
200 grams, ginger 20 restrain at.
The preparation method is the same as that of Example 1 for the food materials composition.
Embodiment 6
A kind of radical cure hypertension of the present embodiment and the food materials composition of cardiovascular and cerebrovascular disease, by 500 grams of apple vinegar, lemon
100 grams, ginger 25 restrain at.
The preparation method is the same as that of Example 1 for the food materials composition.
Test example
In order to illustrate the effect of food materials composition of the invention in terms of radical cure hypertension and cardiovascular and cerebrovascular disease, the present invention
Following clinical trial is carried out.
1, general information
It chooses voluntary receiving food materials composition of the present invention nearly ten years to be treated, is diagnosed as hypertension and cardiovascular and cerebrovascular disease
Patient is used as research object for totally 167, wherein and hypertension 45, coronary heart disease 21, pulmonary heart disease 17, cerebral thrombosis 47, the heart
Muscle infarction 37, it is randomly divided into treatment group (n=83) and control group (n=84).The bases such as gender, age, the course of disease of two groups of patients
Not statistically significant (the P of this data comparing difference>0.05) it, is comparable.
2, treatment method
Treatment group：It gives food materials composition, warm water made from the present embodiment 2 to take, proper honey flavor adjustment can be added,
2 times a day.
Contrast groups：Hypertensive patient takes captopril, each 12.5-25mg, once a day；Patients with Cardiovascular/Cerebrovascular Diseases
Dosed herself with aspirin, each 50-150mg, once a day.
2 months as a treatment course, and all patients eat the acidic materials such as fish, meat, egg in treatment stage less, forbids edible fertilizer
Meat, cream, sweet food and pluck etc. be high-fat, high sugar, high-cholesterol diet.The alkalinity foods such as more feed coarse food grains, veterinary antibiotics
Object, and cooperate and take exercise.
3, curative effect determinate standard
It is effective：Patient by treatment after, hypertensive patient's diastole drops 10mmHg or more, and reach normal range (NR) and/
Or diastole drops 20mmHg or more, but it is not up to normal；Patients with Cardiovascular/Cerebrovascular Diseases is uncomfortable in chest, shortness of breath, cardio palmus shape disappear.
Effectively：For patient after treatment, hypertensive patient's diastolic pressure is declined by less than 10mmHg, but has reached normal range (NR)
And/or diastole drops 10-19mmHg, but decline 30mmHg or more before the relatively treatment of not up to normal and/or systolic pressure；Heart and brain blood
Pipe Disease is uncomfortable in chest, shortness of breath, cardio palmus shape are alleviated.
In vain：For patient after treatment, hypertensive patient is not up to the above standard；Patients with Cardiovascular/Cerebrovascular Diseases symptom is without bright
It is aobvious to improve.
4, result
Two groups of patients are after 1 course of therapy, effective 35 for the treatment of group, and effective 40, invalid 8, treatment is total effective
Rate is 90.36%；Control group effective 28, effective 33, invalid 23, treatment total effective rate is 72.62%；Treatment group's effect
Better than control group, difference has statistical significance.
Typical case：
1, Liu, male 51 years old, suffer from hypertension 8 years, throughout the year giddy dizziness, and indistinctly, body is tired out of strength, lassitude for headache,
Few gas uncomfortable in chest, blood pressure 160/100mmHg once took captopril depressor, more felt dizzy uncomfortable, took orally the embodiment of the present invention 1
Food materials composition obtained even served 2 months 2 times a day, and the symptoms such as dizziness disappear, and blood pressure is normal, and follow-up half a year does not recur.
2, what certain, female, precordialgia before 48 years old, 1 year cannot be alleviated after rest, be diagnosed as coronary heart disease, take orally on the market
Drug without good curative effect, food materials composition made from the oral embodiment of the present invention 3 even served 1 week, pareordia 2 times a day
It pain lasts 3-5 minutes, can voluntarily alleviate after rest, continue to take 2 months, pain of the heart area disappears, and follow-up half a year does not recur.
3, Lee, male, 45 years old, 1 month previous lateral deviation paralysis, the basic imperception of limbs was diagnosed as cerebral thrombosis, takes orally the present invention
Food materials composition made from embodiment 5 even served 2 months 2 times a day, and can get up alone walking, continue to take 2 months, symptom is complete
It totally disappeared mistake, suitable manual labor can be carried out, follow-up half a year does not recur.
4, Zhang, male, 55 years old, bored pain after half a year os presternum was in duration, radiates with back part, be diagnosed as myocardial infarction.
Food materials composition made from the present embodiment 6 is taken, is taken 1 week, pectoralgia is substantially reduced, continues to take 1 month, symptom disappears completely
It removes, does not occur any discomfort when patient takes.
Although above having used general explanation and specific embodiment, the present invention is described in detail, at this
On the basis of invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Therefore,
These modifications or improvements without departing from theon the basis of the spirit of the present invention are fallen within the scope of the claimed invention.
Claims (8)
1. the food materials composition of a kind of radical cure hypertension and cardiovascular and cerebrovascular disease, which is characterized in that the food materials composition is by apple
Fruit vinegar, lemon, ginger are made.
2. the food materials composition of radical cure hypertension according to claim 1 and cardiovascular and cerebrovascular disease, which is characterized in that by weight
Number meter is measured, the food materials composition is made of 500 parts of apple vinegar, 100-200 parts of lemon, 20-60 parts of ginger.
3. the food materials composition of radical cure hypertension according to claim 2 and cardiovascular and cerebrovascular disease, which is characterized in that by weight
Number meter is measured, the food materials composition is made of 500 parts of apple vinegar, 120-160 parts of lemon, 30-50 parts of ginger.
4. the food materials composition of radical cure hypertension according to claim 2 and cardiovascular and cerebrovascular disease, which is characterized in that by weight
Number meter is measured, the food materials composition is made of 500 parts of apple vinegar, 140 parts of lemon, 40 parts of ginger.
5. a kind of preparation method of the food materials composition of radical cure hypertension and cardiovascular and cerebrovascular disease, which is characterized in that the method
Include the following steps：
1) after cleaning lemon, ginger, slice is added in apple vinegar, high fire is boiled, and small fire is closed after enduring half an hour slowly after boiling
Fire；
2) it filters, is saved in the cooling postposition refrigerator of resulting filtrate.
6. the preparation method of the food materials composition of radical cure hypertension according to claim 5 and cardiovascular and cerebrovascular disease, special
Sign is, 500 parts by weight of apple vinegar, lemon 100-200 parts by weight, ginger 20-60 parts by weight.
7. food materials composition described in claim 1 answering in the health care product of preparation radical cure hypertension and cardiovascular and cerebrovascular disease
With.
8. application of the food materials composition described in claim 1 in the drug of preparation radical cure hypertension and cardiovascular and cerebrovascular disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810732438.7A CN108813598A (en) | 2018-07-05 | 2018-07-05 | A kind of food materials composition eradicating hypertension and cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810732438.7A CN108813598A (en) | 2018-07-05 | 2018-07-05 | A kind of food materials composition eradicating hypertension and cardiovascular and cerebrovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108813598A true CN108813598A (en) | 2018-11-16 |
Family
ID=64135767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810732438.7A Pending CN108813598A (en) | 2018-07-05 | 2018-07-05 | A kind of food materials composition eradicating hypertension and cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108813598A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103260431A (en) * | 2010-12-08 | 2013-08-21 | 雀巢产品技术援助有限公司 | Food ingredient comprising hydrolyzed whole grain |
| CN105853948A (en) * | 2015-01-20 | 2016-08-17 | 牙生·玉苏甫 | Health product for preventing and treating cardio-cerebral vascular embolism |
| CN106620629A (en) * | 2017-02-20 | 2017-05-10 | 王智 | Xuesaitong combination drug and preparation method thereof |
| CN107279613A (en) * | 2017-06-27 | 2017-10-24 | 丁保群 | A kind of cerebral thrombus Dietotherapy health drink |
| CN107737321A (en) * | 2017-11-28 | 2018-02-27 | 无限极（中国）有限公司 | A kind of Chinese medicine composition of the promoting flow of qi and blood circulation and its preparation method and application |
-
2018
- 2018-07-05 CN CN201810732438.7A patent/CN108813598A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103260431A (en) * | 2010-12-08 | 2013-08-21 | 雀巢产品技术援助有限公司 | Food ingredient comprising hydrolyzed whole grain |
| CN105853948A (en) * | 2015-01-20 | 2016-08-17 | 牙生·玉苏甫 | Health product for preventing and treating cardio-cerebral vascular embolism |
| CN106620629A (en) * | 2017-02-20 | 2017-05-10 | 王智 | Xuesaitong combination drug and preparation method thereof |
| CN107279613A (en) * | 2017-06-27 | 2017-10-24 | 丁保群 | A kind of cerebral thrombus Dietotherapy health drink |
| CN107737321A (en) * | 2017-11-28 | 2018-02-27 | 无限极（中国）有限公司 | A kind of Chinese medicine composition of the promoting flow of qi and blood circulation and its preparation method and application |
Non-Patent Citations (1)
| Title |
|---|
| 周晓博: "验方十二则", 《开卷有益—求医问药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104054769B (en) | A kind of function bread treating angiocardiopathy and preparation method thereof | |
| KR101090284B1 (en) | Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof | |
| CN101744170B (en) | Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof | |
| CN102224891A (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN103168815A (en) | Gingko tartary buckwheat cookie and manufacturing method thereof | |
| CN107114524A (en) | A kind of hawthorn old ginger tea and preparation method thereof | |
| CN101455378A (en) | Health-care product containing tartary buckwheat and preparation method thereof | |
| KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
| CN104705692A (en) | Dysmenorrhoea conditioning dietotherapy recipe | |
| CN101755878A (en) | Preparation method of weight-reducing cake containing balsam pear, hawthorn and cassia seeds | |
| CN109452417A (en) | A kind of pure natural fat eliminating Weight reducing tea drink and preparation method thereof | |
| JP3634721B2 (en) | Preventive or therapeutic agent for hyperlipidemia | |
| CN108813598A (en) | A kind of food materials composition eradicating hypertension and cardiovascular and cerebrovascular disease | |
| KR20180056199A (en) | Manufacturing method of gum for diet containing Moringa Oleifera extract | |
| CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
| KR101391647B1 (en) | Anti obesity composition | |
| KR101344564B1 (en) | Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia | |
| CN105614675A (en) | Morchella healthcare noodles and making method thereof | |
| CN104605268A (en) | Pork tripe porridge with diabetes treating function and making method of pork trip porrige | |
| CN109602867A (en) | A kind of gout tea and preparation method thereof | |
| CN104304487A (en) | Health milk with efficacy of decreasing blood sugar and preparation method of health milk | |
| EA011008B1 (en) | Method for producing a puree preparation from papaya fruit, and use of the same | |
| CN104255922A (en) | Health care milk suitable for three-high crowd to drink and preparation method of milk | |
| JP2019127439A (en) | Supplement comprising morus alba leaves |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181116 |